By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
The panel consensus is that Chubb (CB) appears cheap at 12x trailing earnings but may be a value trap due to risks such as slowing EPS growth, cyclical pricing in P&C, climate-related claims, and potential liquidity issues from Asian expansion.
Risk: Liquidity mismatch and potential capital calls due to climate-related claims and regulatory stress in Asia, which could trigger multiple compression and suspend the buyback program.
Opportunity: None explicitly stated; the panel focuses on risks and potential pitfalls.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
Chubb (NYSE: CB), the world's largest publicly traded provider of property, supplemental health, and casualty insurance, is a reliable blue chip stock. It's based in Switzerland, and it does business across 54 countries and territories. The current version of the company was created in 2016 after ACE Limited acquired the original Chubb and inherited its brand.
Chubb's stock has rallied 172% over the past ten years. With reinvested dividends, it delivered a total return of 226%. But at $352, it trades at just 12 times trailing earnings, compared to the S&P 500's historically high multiple of 32. It also pays a forward yield of 1.2%. So is it an undervalued, defensive stock to buy today?
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
From 2016 to 2025, Chubb's revenue and EPS grew at CAGRs of 7% and 13%, respectively. That growth was initially driven by ACE's takeover of Chubb, which instantly made it a powerhouse in the property and casualty insurance market.
Chubb dominated the high-net-worth insurance market in the U.S., expanded in Asia, replaced its legacy systems with newer technology platforms, and reduced its exposure to weaker businesses rather than taking on bad risk. Its fixed-income portfolio also benefited from higher interest rates.
From 2025 to 2028, analysts expect Chubb's revenue and EPS to grow at CAGRs of 5% and 7%, respectively. That growth should be driven by the expansion of its middle-market and small commercial accounts to curb its dependence on the softer corporate property market, its deeper push into life insurance across Asia, automated underwriting services, agentic AI upgrades, and the "rolling" of its older, lower-rate fixed income investments into newer, higher-yielding ones.
Chubb also recently raised its dividend for the 33 consecutive year and authorized a new $7.5 billion buyback (equivalent to 5.5% of its current market cap). Those confident moves suggest its core businesses will continue to generate plenty of excess cash for the foreseeable future.
Chubb's scale, diversification, and tech-driven upgrades make it a smart stock to buy today. It has a wide moat and is well insulated from macro headwinds because its customers generally won't cancel their insurance policies to save a few dollars.
While Chubb isn't a high-growth play, it's a stable one that should generate reliable returns. That's probably why Berkshire Hathaway significantly increased its position in Chubb over the past three years, and why it still looks like a screaming bargain at these levels.
Before you buy stock in Chubb, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Chubb wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $371,842! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,244,783!
Now, it’s worth noting Stock Advisor’s total average return is 900% — a market-crushing outperformance compared to 207% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
**Stock Advisor returns as of July 18, 2026. *
Leo Sun has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Berkshire Hathaway. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"CB's valuation discount is real but largely justified by decelerating growth and unmentioned cyclical insurance risks the article downplays."
Chubb (CB) at 12x trailing earnings versus S&P 500 at 32x appears statistically cheap for a 7% EPS CAGR insurer with a 1.2% yield, 33-year dividend streak, and $7.5B buyback. Berkshire's increased stake adds credibility. However, the article glosses over slowing growth: projected EPS CAGR drops from 13% (2016-2025) to 7% (2025-2028), with revenue growth halving to 5%. P&C pricing is cyclical; higher-for-longer rates boosted its fixed-income portfolio but also inflate claims costs. Asia life expansion and AI underwriting face execution and regulatory risks. Total return of 226% over 10 years already prices in much of the moat.
If underwriting margins compress from rising catastrophe losses or a hard market turning soft, CB could easily de-rate to 15-18x earnings, erasing the apparent bargain while its lower growth trajectory limits multiple expansion.
"Chubb's valuation multiple is compressed because the market is pricing in peak interest rate benefits and rising climate-related underwriting risks, not because it is an overlooked bargain."
Chubb (CB) is currently priced as a value trap rather than a growth compounder, despite the article's optimism. While a 12x P/E ratio looks attractive against the S&P 500, insurance is cyclical; the 'rolling' of fixed-income assets into higher yields is a tailwind that is already priced in and likely peaking. The projected deceleration in EPS CAGR from 13% to 7% suggests that the easy gains from post-merger synergies and rising rates are over. Investors are ignoring the catastrophic risk inherent in climate-related claims, which are becoming harder to model and price, potentially leading to significant underwriting volatility that a simple P/E multiple fails to capture.
If Chubb successfully leverages its 'agentic AI' for superior underwriting precision, it could maintain higher margins than peers, justifying a premium over its historical valuation range.
"CB is fairly valued, not cheap—the valuation discount reflects legitimate deceleration in earnings growth, not a hidden bargain."
CB's 12x trailing P/E looks cheap until you stress the forward picture. Analysts expect EPS CAGR to decelerate from 13% (2016-2025) to just 7% (2025-2028)—a 46% slowdown. At 12x on decelerating earnings, you're not getting a margin of safety; you're pricing in perfection on AI automation and Asia expansion that remain unproven at scale. The 1.2% yield barely compensates for duration risk if rates fall. Berkshire's buying is notable but not dispositive—they also own Apple at 30x earnings. The article conflates 'stable' with 'cheap,' which are different things.
If insurance pricing power holds and the fixed-income portfolio repricing actually materializes faster than consensus expects, CB could surprise to the upside—and a 12x multiple on a 7% grower with 33-year dividend history and $7.5B buyback authorization isn't absurd for a defensive compounder.
"The single most important claim is that the cheap valuation may reflect hidden risks to reserves and investment income that could erode earnings, making the upside dependent on multiple favorable macro and underwriting outcomes."
Chubb looks cheap on a 12x trailing earnings basis with a 1.2% forward yield and Berkshire’s larger stake backing a defensive gamble. But the headline multiple hides several risks: 2026–28 growth may disappoint if underwriting conditions worsen, catastrophe losses rise, or inflation pressures reserve adequacy. The investment portfolio is rate-sensitive, so higher rates can sap realized returns and push re-pricing costs into earnings. Asia expansion and heavier life-insurance exposure add regulatory and geopolitical risk. AI underwriting upgrades and dividend growth are not guarantees, and a big buyback is cash-constraint risk if disaster losses spike. In short, “cheap” could be a value trap if macro/rate/claims shocks hit.
Berkshire’s stake and the buyback feel like safety signals, but they don’t guarantee outcomes; a surge in catastrophe losses or a stubbornly volatile rate environment could push earnings down and compress the multiple further.
"Correlated climate perils across business lines threaten reserve adequacy beyond consensus volatility estimates."
Claude correctly flags the 46% EPS CAGR slowdown but underweights second-order climate modeling failure. Catastrophe losses aren't just volatile—they're increasingly correlated across P&C and life lines via secondary perils (wildfire smoke, flood-related mortality). This breaks diversification assumptions baked into the 12x multiple. No one has mentioned reserve adequacy risk if modeled frequencies lag actuals by even 15%.
"Chubb's aggressive share buybacks are highly vulnerable to capital repatriation friction and liquidity shocks from climate-driven reserve calls."
Grok, your focus on correlated secondary perils is vital, but you're missing the regulatory 'trap' in the Asia expansion. Gemini mentioned it, but failed to connect it to capital repatriation. If Chubb's Asian life units face solvency stress, that $7.5B buyback is the first thing to get slashed to preserve domestic reserves. We are ignoring the liquidity mismatch between the portfolio's duration and the potential for sudden, non-linear climate capital calls. This isn't just a valuation play; it's a structural liquidity risk.
"Asia repatriation risk is real but secondary to the systemic correlation risk Grok flagged—simultaneous climate shocks across geographies would be the actual liquidity kill-switch."
Gemini's repatriation trap is underexplored. If Asian life units face solvency pressure, buyback suspension signals distress to markets—triggering multiple compression before earnings even decline. But I'd push back: Chubb's domestic P&C cash generation is fortress-like. Asia represents ~12% of earnings; a stress event there doesn't automatically starve the buyback. The real risk is *correlated* climate losses hitting both domestic and Asian books simultaneously, forcing capital rationing across geographies.
"Cross-border regulatory and liquidity risks could force buyback suspension and capital rationing, nullifying the 'cheap' multiple even if earnings look stable domestically."
Gemini's Asia-regulatory/liquidity concern is the real hinge. If Asian life units face solvency pressure, buybacks may be suspended to shore up domestic capital, even as U.S. P&C cash flows remain strong. That cross-border capital constraint could trigger multiple compression before a clean earnings miss, muting any perceived cheapness. Climate-correlated losses add a second-order layer that worsens liquidity and reserve headroom in both geographies, not just one.
The panel consensus is that Chubb (CB) appears cheap at 12x trailing earnings but may be a value trap due to risks such as slowing EPS growth, cyclical pricing in P&C, climate-related claims, and potential liquidity issues from Asian expansion.
None explicitly stated; the panel focuses on risks and potential pitfalls.
Liquidity mismatch and potential capital calls due to climate-related claims and regulatory stress in Asia, which could trigger multiple compression and suspend the buyback program.